| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |